Delivery Order SPE2DB22D3501-SPE2DB25FVY61
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,329.04 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages). This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $3,329.04. The delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $2,496.78 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,350.29 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The U.S. Defense Logistics Agency (DLA) awarded a $2,418.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the procurement of 4,566,162,380 units of the medication BRILINTA 90 MG TABLET 60S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,157.10 contract is for the delivery of BRILINTA 90 MG TABLET 60S, a prescription medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVY61Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,335.32 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on June 6, 2025, with an ultimate completion date of June 9, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal medical systems worldwide. BRILINTA, an antiplatelet medication used for cardiovascular indications, represents one of the specialty brand-name pharmaceuticals distributed through this strategic contract vehicle to support Defense Health Agency operations and other authorized federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/6/25 |